| |
|
|
|
Vbi Vaccines Inc CS  
|
|
3.37 0.09 (0.03%) |
02-26 16:00 |
|
Open: |
3.315 |
Pre close: |
3.28 |
Target:
|
4.79
|
|
High: |
3.49 |
Low: |
3.245 |
Resistance:
|
4.10
4.83
|
|
Volume: |
6,869,727 |
Market Cap: |
816M |
Support:
|
2.93
2.44
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
3.40
 |
MACD |
MACD(12,26):
|
0.01 |
|
MA(20): |
3.75  |
Signal(12,26,9): |
0.10 |
|
MA(100): |
3.08 |
Stochastic Oscillator |
%K(14,3):
|
16.57 |
|
MA(250): |
2.79 |
%D(3): |
16.23 |
|
Average Volume(K) |
3-Month: |
766128
|
52-Week |
High:
|
6.93 |
|
10-Days: |
646739 |
Low: |
0.69 |
|
RSI |
RSI(14):
|
44.57 |
Change(%): |
159.2 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.206 |
Return on Equity (ttm) |
-31.7 |
Shares Out. (M) |
231.20 |
|
EPS Est. Current Year |
-0.890 |
Return on Assets (ttm) |
-14.9 |
Shares Float (M) |
165.39 |
|
EPS Est. Next Year |
-1.010 |
PEG Ratio |
0.00 |
% Held by Insiders |
3.48 |
|
EPS Est. Next Quarter |
-0.240 |
Qtrly Rev. Growth |
-53.9 |
% Held by Institutions |
57.81 |
|
Forward EPS |
-0.460 |
Gross Profit (p.s.) |
-0.025 |
Shares Short (K) |
44740 |
|
Book Value (p.s.) |
0.690 |
EBITDA (p.s.) |
-0.164 |
P/E |
-16.36 |
|
Sales Per Share |
0.006 |
Qtrly Earnings Growth |
0.00 |
P/BV |
4.88 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-39.09 |
P/S |
530.03 |
|
Operating Margin |
-2690.21 |
Levered Free Cash Flow
(M) |
-23.69 |
P/CF |
-19.93 |
|
|
|
|
|
|
